1. Home
  2. GSIW vs EVGN Comparison

GSIW vs EVGN Comparison

Compare GSIW & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIW
  • EVGN
  • Stock Information
  • Founded
  • GSIW 2016
  • EVGN 1999
  • Country
  • GSIW Hong Kong
  • EVGN Israel
  • Employees
  • GSIW N/A
  • EVGN N/A
  • Industry
  • GSIW
  • EVGN Agricultural Chemicals
  • Sector
  • GSIW
  • EVGN Industrials
  • Exchange
  • GSIW Nasdaq
  • EVGN Nasdaq
  • Market Cap
  • GSIW 8.3M
  • EVGN 7.3M
  • IPO Year
  • GSIW 2023
  • EVGN N/A
  • Fundamental
  • Price
  • GSIW $1.15
  • EVGN $1.10
  • Analyst Decision
  • GSIW
  • EVGN Strong Buy
  • Analyst Count
  • GSIW 0
  • EVGN 1
  • Target Price
  • GSIW N/A
  • EVGN $3.50
  • AVG Volume (30 Days)
  • GSIW 2.1M
  • EVGN 40.8K
  • Earning Date
  • GSIW 12-31-2024
  • EVGN 05-21-2025
  • Dividend Yield
  • GSIW N/A
  • EVGN N/A
  • EPS Growth
  • GSIW N/A
  • EVGN N/A
  • EPS
  • GSIW N/A
  • EVGN N/A
  • Revenue
  • GSIW $1,313,795.00
  • EVGN $6,765,000.00
  • Revenue This Year
  • GSIW N/A
  • EVGN $68.62
  • Revenue Next Year
  • GSIW N/A
  • EVGN $34.94
  • P/E Ratio
  • GSIW N/A
  • EVGN N/A
  • Revenue Growth
  • GSIW N/A
  • EVGN N/A
  • 52 Week Low
  • GSIW $0.35
  • EVGN $0.95
  • 52 Week High
  • GSIW $12.30
  • EVGN $7.50
  • Technical
  • Relative Strength Index (RSI)
  • GSIW 78.55
  • EVGN 42.30
  • Support Level
  • GSIW $0.73
  • EVGN $1.06
  • Resistance Level
  • GSIW $0.77
  • EVGN $1.14
  • Average True Range (ATR)
  • GSIW 0.10
  • EVGN 0.07
  • MACD
  • GSIW 0.03
  • EVGN -0.01
  • Stochastic Oscillator
  • GSIW 86.84
  • EVGN 10.81

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

Share on Social Networks: